What about that 2022 ICER report on anti-obesity medications? DOI
Harold Bays

Obesity Pillars, Journal Year: 2022, Volume and Issue: 4, P. 100038 - 100038

Published: Oct. 1, 2022

Language: Английский

Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 DOI Creative Commons
Harold Bays,

Shagun Bindlish,

Tiffany Lowe Clayton

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 5, P. 100056 - 100056

Published: Jan. 28, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of type 2 diabetes mellitus (T2DM), obesity-related cardiometabolic risk factor.

Language: Английский

Citations

32

Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023 DOI Creative Commons

Tiffany Lowe Clayton,

Angela Fitch, Harold Bays

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100083 - 100083

Published: Aug. 7, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) provides an overview of the mechanisms and treatment obesity hypertension.

Language: Английский

Citations

18

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023 DOI Creative Commons

Shagun Bindlish,

Jennifer Ng,

Wissam Ghusn

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100092 - 100092

Published: Oct. 19, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians with an overview on obesity, thrombosis, venous disease, lymphatic and lipedema.

Language: Английский

Citations

13

Therapeutic potential of gallic acid in obesity: Considerable shift! DOI
Prabhat Kumar Behera, Sushma Devi, Neeraj Mittal

et al.

Obesity Medicine, Journal Year: 2022, Volume and Issue: 37, P. 100473 - 100473

Published: Dec. 13, 2022

Language: Английский

Citations

19

Obesity Management in Primary Care: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025 DOI Creative Commons
N. J. Pennings, Catherine Varney,

Stephanie L. Hines

et al.

Obesity Pillars, Journal Year: 2025, Volume and Issue: unknown, P. 100172 - 100172

Published: March 1, 2025

This collaboration from the Obesity Medicine Association (OMA) and American College of Osteopathic Family Physicians (ACOFP) examines obesity management a primary care perspective. joint perspective is based upon scientific evidence, clinical experience authors, peer review by OMA ACOFP leadership. The goal to identify answer sentinel questions about perspective, utilizing evidence-based publications, guided expert experience. disease that contributes both biomechanical complications most common cardiometabolic abnormalities encountered in care. Barriers impede optimal patients with include failure recognize as disease, lack accurate diagnosis, insufficient access treatment resources, inadequate training, time, adequate reimbursement adverse impact bias, stigma, discrimination. physicians are often first line healthcare setting. affords early intervention opportunities prevent and/or treat overweight obesity. Patient enhanced when clinicians risks benefits anti-obesity medications bariatric procedures, well long-term follow-up. Practical tools regarding 4 pillars nutrition therapy, physical activity, behavior modification, medical interventions (anti-obesity surgery) may assist improve health lives living

Language: Английский

Citations

0

Obesity management for cardiovascular disease prevention DOI Creative Commons
Rama Hritani, Mahmoud Al Rifai, Anurag Mehta

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 7, P. 100069 - 100069

Published: May 23, 2023

Obesity is a complex disease that leads to higher morbidity and mortality its rate in the United States rapidly rising. Targeting obesity management one of cornerstones preventive medicine. Early intervention can significantly reduce risk developing cardiovascular disease. While it well known lifestyle interventions such as healthful nutrition routine physical activity are first most important step management, some do not achieve desired results require further therapies. A literature review was conducted, included clinical documents, public scientific citations peer articles evaluate anti-obesity medications, endoscopic procedures bariatric surgeries obesity. We also effects these on weight loss, reduction side effects. This summarizes recent evidence for different approaches including common surgeries. For more detailed options discussed, we recommend reviewing Medicine Association Clinical Practice Statement [1]. Management reduces risk, improves metabolic parameters other health outcomes. Different available, hence, high level awareness growing epidemic needed ensure timely referrals medicine specialists.

Language: Английский

Citations

9

Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study DOI Creative Commons
Harold Bays, Daniel S. Hsia, Lan Thi Nguyen

et al.

Obesity Pillars, Journal Year: 2024, Volume and Issue: 9, P. 100099 - 100099

Published: Jan. 8, 2024

A fixed-dose combination of phentermine and extended-release topiramate (PHEN/TPM - approved for weight management) has demonstrated in-clinic reduction blood pressure (BP). Ambulatory BP monitoring (ABPM) may be a better predictor cardiovascular disease risk than BP.

Language: Английский

Citations

2

Investigation of the effects of polyherbal formulations against the combination of a high-fat cafeteria diet along with exercise modalities DOI Creative Commons

M. Ramasamy,

Karthikeyan Elumalai, S. Srinivasan

et al.

Advances in Biomarker Sciences and Technology, Journal Year: 2024, Volume and Issue: 6, P. 35 - 45

Published: Jan. 1, 2024

The aim of the present study was to make a polyherbal formulation three herbs that would offset negative effects high-fat cafeteria diet on rats and beneficial exercise. ingredients for this herbal remedy included water extract Garcinia cambogia fruit, Trigonella foenum-graecum seed, Glycyrrhiza glabra root in 1:1:1 ratio. Nine groups six male Wistar albino were chosen. Animals Group I normal fed standard diet; animals II given HFCD prevent disease; III plus exercise; while Groups IV V PHF at doses 400 200 mg/kg p. o. Daily, respectively, addition HFCD; VI VII exercised obese prevented from gaining more weight had their serum glucose, total cholesterol, triglycerides, low-density lipoprotein very cholesterol levels lowered. HDL raised. Further, liver biopsy showed increased mononuclear cells; fat globules numbered less; enzymes cells are regenerating lower levels. exercise exhibited significant anti-obesity efficacy o.; effect equivalent orlistat research employed HFCD-induced as model investigate joint against obesity.

Language: Английский

Citations

1

Obesity Management in Women DOI
Henry Bohler

Nursing Clinics of North America, Journal Year: 2024, Volume and Issue: 59(4), P. 593 - 609

Published: Sept. 23, 2024

Language: Английский

Citations

1

Universal Prior Authorization Template for glucagon like peptide-1 based anti-obesity medications: An Obesity Medicine Association proposal DOI Creative Commons
Harold Bays, C. Brown, Angela Fitch

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100079 - 100079

Published: Aug. 2, 2023

Language: Английский

Citations

3